Covid vaccines are arriving – and so are new problems

15 December 2020 (Last Updated December 15th, 2020 07:10)

15 December

David Wessel, a journalist and director of the Hutchins Centre on Fiscal and Monetary Policy, shared an article on the next six months after vaccine approvals being vaccine purgatory, a period where people will despair, worry and be confused about who will be prioritised for inoculations and how long will people have to wait their turn.

While the end of the pandemic is in sight, economists believe that developed nations such as the US will take several months for people to be vaccinated to resume normal life.

Therefore, the next six months will be chaotic for people, with possibilities in vaccine delays, fights over prioritising inoculation, and how the vaccinated are recovering and how they should exercise caution, the article detailed.

The question before nations is how long will the purgatory last, and how effective will programmes such as the Operation Warp Speed be in meeting their required deadline of vaccinating nearly all of the US by June, the article noted.

Economists further believe that vaccine developers such as Pfizer and Moderna, the FDA-approved forerunners in the vaccine race, cannot remain complacent and hit delays in manufacturing.

Likewise, AstraZeneca and Johnson & Johnson need to fast-track approval of their vaccine candidates early next year.

Additionally, one’s anguish will also depend on where one lives.

For instance, every state in the US is authorised to use the vaccines the way it wants once it receives them.

Consequently, one could qualify as an essential worker in Illinois but not in Indiana.

Therefore, the process of vaccine administration will be local, flexible, and most likely inconsistent and unfair, the article noted.

Read more